- Home
- ELWS vs CMND Comparison
ELWS vs CMND Comparison
Compare ELWS & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELWS
- CMND
- Stock Information
- Founded
- ELWS 2018
- CMND 2017
- Country
- ELWS Japan
- CMND Canada
- Employees
- ELWS N/A
- CMND N/A
- Industry
- ELWS
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- ELWS
- CMND Health Care
- Exchange
- ELWS Nasdaq
- CMND Nasdaq
- Market Cap
- ELWS 6.2M
- CMND 6.0M
- IPO Year
- ELWS 2023
- CMND N/A
- Fundamental
- Price
- ELWS $2.15
- CMND $1.03
- Analyst Decision
- ELWS
- CMND
- Analyst Count
- ELWS 0
- CMND 0
- Target Price
- ELWS N/A
- CMND N/A
- AVG Volume (30 Days)
- ELWS 12.5K
- CMND 55.0K
- Earning Date
- ELWS 03-03-2025
- CMND 03-13-2025
- Dividend Yield
- ELWS N/A
- CMND N/A
- EPS Growth
- ELWS N/A
- CMND N/A
- EPS
- ELWS N/A
- CMND N/A
- Revenue
- ELWS $2,292,406.00
- CMND N/A
- Revenue This Year
- ELWS N/A
- CMND N/A
- Revenue Next Year
- ELWS N/A
- CMND N/A
- P/E Ratio
- ELWS N/A
- CMND N/A
- Revenue Growth
- ELWS 404.13
- CMND N/A
- 52 Week Low
- ELWS $1.04
- CMND $0.95
- 52 Week High
- ELWS $8.68
- CMND $2.30
- Technical
- Relative Strength Index (RSI)
- ELWS 44.92
- CMND 34.60
- Support Level
- ELWS $2.01
- CMND $1.04
- Resistance Level
- ELWS $2.39
- CMND $1.11
- Average True Range (ATR)
- ELWS 0.25
- CMND 0.06
- MACD
- ELWS 0.05
- CMND -0.00
- Stochastic Oscillator
- ELWS 43.73
- CMND 10.07
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.